Genocea Biosciences Inc: Slips on planned 10 mln share offering

Genocea Biosciences

18/06/2019 21:36

** Genocea Biosciences  GNCA.O  shares falling 5.3% to $4.85
after hours as co looks to raise equity
    ** Cancer immunotherapy developer commences 10 mln share
follow-on with SVB Leerink and Stifel acting as joint
bookrunners, joined by Baird and Needham as co-mgrs  urn:newsml:reuters.com:*:nGNXRK8BC
    ** Deal size represents ~70% of GNCA outstanding shares and
80% of co's free float as of May 21, per Refinitiv data
    ** GNCA jumped 20% on Jun 3 after positive data from ongoing
trial of GEN-009, its lead cancer treatment vaccine, at 2019
Annual Meeting of the American Society of Clinical Oncology
(ASCO)  urn:newsml:reuters.com:*:nL4N23A2X7
    ** Stock closed down 4.8% at $5.12 in regular session Tues.
Shares have more than doubled YTD

 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))